WELCOME TO The PHARMACEUTICAL REPORT
Demystifying content marketing for the pharma industry
November 10, 2022
I'm For Real
Enter your details once to access all our information and resources
Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical and biopharmaceutical products and therapies, as well as nuclear imaging products.
whitePaper | November 3, 2022
This document is published by the World Economic Forum as a contribution to a project, insight area or interaction. The findings, interpretations and conclusions expressed herein are a result of a collaborative process facilitated and endorsed by the World Economic.
whitePaper | November 19, 2022
In the second year of the pandemic, dealmaking continued to take place at record levels, maintaining much of the momentum created during 2020.
whitePaper | January 18, 2023
Reaching a post-pandemic era is an alluring prospect for almost everyone around the world after the disruptions of the past three years.
whitePaper | November 25, 2022
To meet the needs of a growing range of external stakeholders, many life science companies are changing the ways that they disseminate information.
whitePaper | November 14, 2022
Rising drug spending and increased desire for expenditure controls are consistent themes across the US, Europe, and emerging markets.
whitePaper | June 22, 2022
The technologic and pharmacologic advances that have enabled researchers to take aim at previously untreatable diseases have contributed to an increase in the number of molecules in the development pipeline that are challenging and difficult to manufacture.
Keep me plugged in with the best
Join thousands of your peers and receive our weekly newsletter with the latest news, industry events, customer insights, and market intelligence.
Put your news, events, company, and promotional content in front of thousands of your peers and potential customers.
Not a member yet? Not a problem, Sign Up
Sign up to contribute and publish your news, events, brand, and content with the
community for FREE